CAV1 and systemic sclerosis: In systemic sclerosis, caveolin-1 is thought to be anti-fibrotic by its effect on TGFβ signalling by receptor degradation [16]; as a model of accelerated fibrosis, renal allograft failure has been associated with CAV1 SNP rs4730751 donor genotype [7].